Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug DevelopmentCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52025-12-010PRE
Leveraging quantitative systems pharmacology modeling for elranatamab regimen optimization in relapsed or refractory multiple myeloma利用定量系统药理学模型优化elranatamab方案在复发或难治性多发性骨髓瘤中的应用npj Systems Biology and ApplicationsIF3.52025-09-010OAAI
A Novel Two-Part Mixture Model for the Incidence and Time Course of Cytokine Release Syndrome After Elranatamab Dosing in Multiple Myeloma PatientsCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52025-02-161OAAI
An integrated quantitative systems pharmacology virtual population approach for calibration with oncology efficacy endpointsCPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGYIF32024-11-070OAAI
Realizing the promise of Project Optimus: Challenges and emerging opportunities for dose optimization in oncology drug developmentCPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGYIF32024-03-2118OA
Order-of-mutation effects on cancer progression: Models for myeloproliferative neoplasmCANCER RESEARCHIF16.62024-02-010PRE
Machine learning and statistical prediction of patient quality-of-life after prostate radiation therapyCOMPUTERS IN BIOLOGY AND MEDICINEIF6.32021-02-0116OAAI
A Mathematical Model for DC Vaccine Treatment of Type I DiabetesFRONTIERS IN PHYSIOLOGYIF3.42019-09-065OAAI
Stronger net posterior cortical forces and asymmetric microtubule arrays produce simultaneous centration and rotation of the pronuclear complex in the early Caenorhabditis elegans embryoMOLECULAR BIOLOGY OF THE CELLIF2.72016-11-0710OAAI
A Mathematical Model of Force Generation by Flexible Kinetochore-MicrotubuleBIOPHYSICAL JOURNALIF3.12014-03-018OAAI